跳至主要内容
临床试验/JPRN-UMIN000014552
JPRN-UMIN000014552已完成2 期

A phase II study of talc poudrage for patients with malignant pleural effusions - A phase II study of talc poudrage for patients with malignant pleural effusions

ishichita General Hospital0 个研究点目标入组 7 人开始时间: 2014年7月14日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
7

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Hypersensitivity to talc. 2. Hypersensitivity to lidocaine hydrochrolide. 3. Severe infection. 4. Severe hypoxemia despite oxgen therapy. 5. Uncontrolled angina or heart failure. 6. Myocardical infarction within 30 days of consent. 7. Severe bleeding diathesis. INR > 2.0 or platelet <60000/mm3. 8. Severe pleural adhesion. 9. Indication for bilateral pleurodesis. 10. History of pleurodeis of affected side. 11. Preganant or during lactation. Patient who hopes to bear child, or who can not keep contraceptive maneuver. 12. Inappropriate to enter this trial judged by the physician in charge

研究者

发起方
ishichita General Hospital

相似试验